(19)

(11)

EP 4 823 670 A1

(12)

(43) Date of publication: 21.10.2026 Bulletin 2026/43 (21) Application number: 24828984.5 (22) Date of filing: 11.12.2024

(51) International Patent Classification (IPC):  A61N 1/36(2006.01) A61B 5/388(2021.01) A61N 1/05(2006.01) A61B 5/377(2021.01) A61B 5/00(2006.01) A61N 1/372(2006.01) (52) Cooperative Patent Classification (CPC): A61N 1/36139; A61N 1/3606; A61N 1/0551; A61N 1/37247; A61N 1/36185; A61N 1/0534; A61B 5/377; A61B 5/388; A61B 5/7246 (86) International application number: PCT/US2024/059577 (87) International publication number: WO 2025/128704 (19.06.2025 Gazette 2025/25)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: GE KH MA MD TN (30) Priority: 12.12.2023 US 202363609115 P (71) Applicant: Boston Scientific Neuromodulation Corporation Valencia, CA 91355 (US)

(72) Inventors: ZHANG, Tianhe Studio City, California 91604 (US) BLOCK, Jessica Los Angeles, California 90026 (US) LARCOM, Jonathan Philip Simi Valley, California 93065 (US) MOORE, Lisa Denise Glendale, California 91214 (US) CARBUNARU, Rafael Valley Village, California 91607 (US) (74) Representative: Vossius & Partner Patentanwälte Rechtsanwälte mbB  Siebertstraße 3 81675 München 81675 München (DE)